New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
12:33 EDTINOInovio prepping for failure of cervical cancer vaccine study, TheStreet says
With results due "any day" from Inovio Pharmaceuticals' phase II study of its vaccine for cervical pre-cancerous lesions, the company's CEO is "walking back expectations" and "laying the foundation for a massive spin job," according to TheStreet's Adam Feuerstein. The author said he suspects Inovio already has data in hand and that recent "red flags" by CEO Joseph Kim and the company may be intended to "cushion the vaccine's failure." Reference Link
News For INO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:16 EDTINOPiper Jaffray and the Alliance for Regenerative Medicine co-host conference
3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link
March 23, 2015
06:53 EDTINOInovio to host investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use